Agilent Technologies logo
Agilent Technologies A
€ 98.48 3.81%

Quartalsbericht 2025-Q4
hinzugefügt 03.03.2026

report update icon

Agilent Technologies Kurzfristige Verbindlichkeiten 2011-2026 | A

Kurzfristige Verbindlichkeiten Jährlich Agilent Technologies

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
1.71 B 1.47 B 2.08 B 1.16 B 1.26 B 945 M 976 M 1.7 B 1.6 B 1.89 B 1.84 B

Alle Zahlen in USD-Währung

Indikatorenreichweite aus Jahresberichten

Höchstwert Mindestwert Durchschnitt
2.08 B 945 M 1.51 B

Kurzfristige Verbindlichkeiten anderer Aktien in der Diagnostik & Forschung

Name Kurzfristige Verbindlichkeiten Preis % 24h Marktkapitalisierung Land
Accelerate Diagnostics Accelerate Diagnostics
AXDX
66.6 M - -61.36 % $ 2.46 M usaUSA
CareDx, Inc CareDx, Inc
CDNA
89.8 M $ 20.81 0.05 % $ 1.11 B usaUSA
Co-Diagnostics Co-Diagnostics
CODX
3.54 M $ 1.55 1.31 % $ 2.06 M usaUSA
Castle Biosciences Castle Biosciences
CSTL
49.4 M $ 24.49 1.03 % $ 680 M usaUSA
Akumin Akumin
AKU
169 M - -17.87 % $ 25.9 M canadaCanada
Biocept Biocept
BIOC
5.51 M - -13.05 % $ 7.29 M usaUSA
Fulgent Genetics Fulgent Genetics
FLGT
72.9 M $ 15.19 2.64 % $ 459 M usaUSA
Aspira Women's Health Aspira Women's Health
AWH
3.46 M - -6.19 % $ 10.5 M usaUSA
Chembio Diagnostics Chembio Diagnostics
CEMI
39.3 M - 0.22 % $ 16.8 M usaUSA
Oxford Immunotec Global PLC Oxford Immunotec Global PLC
OXFD
13.8 M - - $ 562 M britainBritain
Check-Cap Ltd. Check-Cap Ltd.
CHEK
1.81 M - - $ 9.42 M israelIsrael
Heska Corporation Heska Corporation
HSKA
39.6 M - - $ 1.31 B usaUSA
HTG Molecular Diagnostics HTG Molecular Diagnostics
HTGM
8.27 M - -20.0 % $ 1.06 M usaUSA
ICON Public Limited Company ICON Public Limited Company
ICLR
2.8 B $ 118.33 1.86 % $ 9.76 B irlandaIrlanda
Illumina Illumina
ILMN
1.55 B $ 126.74 5.29 % $ 20.2 B usaUSA
DermTech DermTech
DMTK
13.4 M - -11.32 % $ 2.94 M usaUSA
Global Cord Blood Corporation Global Cord Blood Corporation
CO
647 M - - $ 399 M chinaChina
Fluidigm Corporation Fluidigm Corporation
FLDM
54.2 M - 1.08 % $ 308 M usaUSA
Charles River Laboratories International Charles River Laboratories International
CRL
1.12 B $ 166.97 1.91 % $ 8.28 B usaUSA
PRA Health Sciences, Inc. PRA Health Sciences, Inc.
PRAH
1.27 B - - $ 10.7 B usaUSA
Lantheus Holdings Lantheus Holdings
LNTH
333 M $ 84.62 4.25 % $ 5.71 B usaUSA
Enzo Biochem Enzo Biochem
ENZ
24.8 M - -8.98 % $ 14.8 K usaUSA
Exact Sciences Corporation Exact Sciences Corporation
EXAS
641 M - - $ 19.8 B usaUSA
Medpace Holdings Medpace Holdings
MEDP
1.34 B $ 418.66 1.23 % $ 12.1 B usaUSA
Guardant Health Guardant Health
GH
303 M $ 87.08 4.4 % $ 10.9 B usaUSA
Motus GI Holdings Motus GI Holdings
MOTS
3.27 M - -34.28 % $ 263 K israelIsrael
Myriad Genetics Myriad Genetics
MYGN
134 M $ 4.75 1.5 % $ 440 M usaUSA
Interpace Biosciences Interpace Biosciences
IDXG
5.1 M $ 1.98 -0.5 % $ 8.76 M usaUSA
NeoGenomics NeoGenomics
NEO
88.3 M $ 9.26 3.35 % $ 1.19 B usaUSA
QIAGEN N.V. QIAGEN N.V.
QGEN
512 M - - $ 10.6 B niderlandNiderland
Biomerica Biomerica
BMRA
1.74 M $ 2.18 0.93 % $ 5.01 M usaUSA
Laboratory Corporation of America Holdings Laboratory Corporation of America Holdings
LH
2.82 B $ 256.8 -0.13 % $ 21.4 B usaUSA
National Research Corporation National Research Corporation
NRC
36.6 M $ 16.46 -0.48 % $ 368 M usaUSA
Celcuity Celcuity
CELC
44.2 M $ 121.35 1.97 % $ 5.67 B usaUSA
Natera Natera
NTRA
310 M $ 206.16 5.86 % $ 20.3 B usaUSA
Neogen Corporation Neogen Corporation
NEOG
174 M $ 9.4 4.33 % $ 2.04 B usaUSA
Invitae Corporation Invitae Corporation
NVTA
108 M - - $ 21.2 M usaUSA
Quest Diagnostics Incorporated Quest Diagnostics Incorporated
DGX
2.28 B $ 194.2 2.58 % $ 21.6 B usaUSA
OpGen OpGen
OPGN
634 K - -16.95 % $ 1.54 M usaUSA
Organovo Holdings Organovo Holdings
ONVO
3.74 M - -2.3 % $ 19.4 M usaUSA
PerkinElmer PerkinElmer
PKI
1.33 B - -0.91 % $ 14.7 B usaUSA
Exagen Exagen
XGN
14.2 M $ 2.9 5.07 % $ 62.5 M usaUSA
Precipio Precipio
PRPO
3.75 M $ 30.9 3.21 % $ 49.6 M usaUSA
Burning Rock Biotech Limited Burning Rock Biotech Limited
BNR
372 M $ 17.0 4.68 % $ 179 M chinaChina
Personalis Personalis
PSNL
31.1 M $ 5.52 9.52 % $ 327 M usaUSA